Eco Div of Tracer Tech Inc

Tracer Technologies Inc. is a well-established manufacturer with over 40 years of experience, located in the Boston metropolitan area. The company specializes in producing lithium-based specialty cells and battery packs for various applications, including medical devices and portable tools. Their Battery Pack Division focuses on creating replacement packs for tools and communication devices, with products utilized across diverse fields such as healthcare and oil and gas exploration. Tracer Technologies offers a range of battery types, including Lithium Primary Cells, Lithium-Ion Cells, Nickel Metal Hydride Cells, and Nickel Cadmium Cells. Generated from the website

MagiQ Technologies is a leading provider of optical sensor innovations with applications in defense, telecommunications, and energy exploration. The company specializes in solutions such as electromagnetic interference mitigation, RF interference cancellation, and optical seismic surveillance, all designed to enhance operational effectiveness and secure critical data. With a commitment to advancing technology, MagiQ has successfully demonstrated high-temperature fiber-optic accelerometers and consistently engages in strategic partnerships and research initiatives. Their proprietary technologies support industries like oil and gas, emphasizing accurate exploration and data-driven solutions to meet the complex challenges of the modern era. Generated from the website

Strategic Science Technologies, LLC (SST) is a privately funded biotechnology company based in Cambridge, MA. They specialize in developing innovative topical drug delivery technology to formulate active pharmaceutical ingredients, providing targeted local delivery at therapeutic levels. With three programs already in clinical trials, SST is focused on becoming the first FDA approved product for the treatment of Female Sexual Arousal Disorder (FSAD). SST has recently made headlines with their collaboration with Dar Bioscience, Inc., initiating a content validity study and entering into a license and collaboration agreement for a potential therapy called Sildenafil Cream, 3.6. This product holds the potential to receive the first FDA approval for FSAD, addressing a significant unmet medical need. With their cutting-edge technology and dedication to advancing treatment options, SST is poised to make a significant impact in the field of biotechnology and women's health.Generated from the website